Form 8.3 - UDG HEALTHCARE PLC

RNS Number : 5933C

Aviva PLC

21 June 2021

 

Ap19

FORM   8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.  KEY   INFORMATION

Nameofpersondealing (Note 1)	AVIVA PLC AND ITS SUBSIDIARIES
Companydealtin	UDG HEALTHCARE PLC
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)	ORD EUR0.05
Date of dealing	18/06/2021

2.  INTERESTS AND SHORT POSITIONS

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

	Long			Short
	Number		(%)	Number		(%)
(1)Relevantsecurities	4,564,056*  1.81
(2) Derivatives (other than options)
(3)Optionsandagreementstopurchase/sell
Total	4,564,056*  1.81

*Aviva plc does not have investment discretion over 1,031,702 shares, however full voting authority is retained.

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   3)

Classofrelevantsecurity:	Long			Short
	Number		(%)	Number		(%)
(1)Relevantsecurities
(2) Derivatives (other than options)
(3)Optionsandagreementstopurchase/sell
Total

Ap20

1.  DEALINGS  (Note   4)

(a)  Purchases and sales

Purchase/sale	Numberofrelevantsecurities	Priceperunit (Note 5)
PURCHASE	247	GBP10.440000

(b)  Derivatives transactions (other than options transactions)

Productname, e.g. CFD	Natureoftransaction (Note 6)	Numberofrelevantsecurities (Note 7)	Priceperunit (Note 5)

(c)  Options transactions in respect of existing relevant securities

(i)  Writing, selling, purchasing or varying

Productname, e.g. call option	Writing, selling,purchasing,varyingetc.	Numberofsecurities towhichtheoptionrelates (Note 7)	Exercise price	Type, e.g.American,Europeanetc.	Expiry date	Optionmoney paid/receivedperunit (Note 5)

(ii)  Exercising

Productname, e.g. call option	Numberofsecurities	Exercisepriceper unit (Note 5)

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2.  OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative

 referred to on this form is referenced. If none, this should be stated.

  Aviva plc does not have investment discretion over part of the holding, however full voting authority is retained.

Is a Supplemental Form 8 attached?  (Note   9)    NO

Dateofdisclosure	21 JUNE 2021
Contact name	MICHAEL DUNHILL
Telephone number	00 44 1603 683853
If aconnectedEFM,nameofofferee/offerorwithwhichconnected
If aconnectedEFM,statenatureofconnection (Note 10)

 

END

 

 

ISEEADKFALSFEFA